disopyramide has been researched along with propafenone in 62 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (53.23) | 18.7374 |
1990's | 15 (24.19) | 18.2507 |
2000's | 10 (16.13) | 29.6817 |
2010's | 3 (4.84) | 24.3611 |
2020's | 1 (1.61) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Delbressine, L; Harris, N; Kane, KA; Muir, AW; Winslow, E | 1 |
Inoue, H; Nozaki, A; Saihara, S; Sugimoto, T; Usui, M; Yamashita, T | 1 |
Arakawa, K; Hiroki, T; Kumagai, K; Yamanouchi, Y | 1 |
Campbell, JK; Marshall, RJ; Winslow, E | 1 |
Inoue, H; Nozaki, A; Sugimoto, T; Yamashita, T | 1 |
Korsukewitz, J; Schmutzler, H; Wegscheider, K | 1 |
Kleinrok, A; Markiewicz, M; Rumiński, W; Tomaszewski, A | 1 |
Beuscart, R; Caron, J; Connell, C; Dupuis, B; Kacet, S; Lekieffre, J; Libersa, C; Pladys, A; Wajman, A | 1 |
Bell, P; Martorana, M; Winslow, E | 1 |
Grzelak, H; Kowalewski, W; Kowalisko, A; Lukasik, S; Nowosad, H | 1 |
Hoffman, BF; Spinelli, W | 1 |
Borodkin, VV; Dudaev, VA; Liusov, VA; Rudakov, AV | 1 |
Somberg, J | 1 |
Roden, DM; Siddoway, LA; Woosley, RL | 1 |
Amiel, A; Boutaud, P; Ciber, M; Demange, J; Guillem, JP; Herpin, D; Maarek-Charbit, M | 1 |
Huang, SK; Marcus, FI | 1 |
Bonazzi, O; Facchini, M; Priori, SG; Schwartz, PJ; Varisco, T | 1 |
Bandh, S; Bjerle, P; Jonason, T; Lidell, C; Nilsson, G; Nilsson, H; Olofsson, BO; Ringqvist, I | 1 |
Boroomand-Rashti, K; McKinnon, J; Rabkin, SW; Rotem, CE | 1 |
Sakai, K; Takagi, M; Yamazaki, T | 1 |
Ambrosioni, E; Bertaccini, P; Bracchetti, D; Cantelli, I; Naccarella, F; Palmieri, M | 1 |
Hirosawa, K; Kasanuki, H; Onishi, S | 1 |
Podrid, PJ | 1 |
Atarashi, H; Hayakawa, H | 1 |
Schmitz, W | 1 |
Attuel, P; Coumel, P; Georgiopoulos, G; Halkidis, H; Leclercq, JF; Maisonblanche, P | 1 |
Somberg, JC | 1 |
Kenedi, P | 1 |
Lüderitz, B | 1 |
Assayag, P; Cauchemez, B; Coumel, P; Leclercq, JF; Maisonblanche, P | 1 |
Bettini, R; Dal Forno, P; Disertori, M; Furlanello, F; Gramegna, L; Inama, G; Vergara, G | 1 |
Bomba, E; Bracchetti, D; Capucci, A; Lombardi, G; Naccarella, F; Palmieri, M | 1 |
Delise, P; Di Pede, F; Piccolo, E; Raviele, A | 1 |
Angermann, C; Jahrmärker, H | 1 |
Mouselimis, N; Wester, HA | 1 |
Funke, H; Grube, E; Neumann, G | 1 |
Böcker, K; Köhler, E; Loogen, F; Seipel, L | 1 |
Bracchetti, D; del Corso, P; Lombardi, G; Naccarella, F; Palmieri, M | 1 |
Carlsson, B; Drvota, V; Häggblad, J; Sylvén, C | 1 |
Grey, E; Silverman, DI | 1 |
Liu, JX; Takeo, S; Tanonaka, K; Yamamoto, K | 1 |
Lüderitz, B; Manz, M | 1 |
Brechenmacher, C; Chauvin, M; Koenig, A; Theolade, R | 1 |
Asayama, J; Inoue, D; Nakagawa, M; Ochiai, M; Omori, I | 1 |
Akaike, N; Inomata, N; Ishihara, T; Ohno, T | 1 |
Crijns, HJ; Gosselink, AT; Lie, KI | 1 |
Jamali, F; Mehvar, R | 1 |
Beurrier, D; Brembilla-Perrot, B; Danchin, N; Houplon, P; Jacquemin, L; Louis, P; Terrier de la Chaise, A | 1 |
Fujimura, A; Sakamoto, K; Shiga, T; Tsuruoka, S; Wakaumi, M | 1 |
Scharf, C | 1 |
Bai, J; Gao, M; Lo, A; Lu, Y; Zhang, H; Zhao, J; Zhu, Y | 1 |
9 review(s) available for disopyramide and propafenone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
[Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Quinidine; Sodium; Tocainide | 1980 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil | 1993 |
[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Disopyramide; Electric Countershock; Flecainide; Humans; Propafenone; Quinidine; Recurrence; Sotalol | 1993 |
Bioequivalence of chiral drugs. Stereospecific versus non-stereospecific methods.
Topics: Adrenergic Uptake Inhibitors; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Area Under Curve; Computer Simulation; Disopyramide; Doxepin; Drug Interactions; Flurbiprofen; Food-Drug Interactions; Guidelines as Topic; Hydroxychloroquine; Ibuprofen; Nadolol; Nortriptyline; Propafenone; Stereoisomerism; Therapeutic Equivalency; Verapamil | 1997 |
[Atrial flutter and fibrillation].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents | 2005 |
10 trial(s) available for disopyramide and propafenone
Article | Year |
---|---|
[Idiopathic ventricular tachyarrhythmia. Spontaneous variability and effect of various antiarrhythmic agents].
Topics: Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; Dose-Response Relationship, Drug; Drug Evaluation; Electrocardiography; Female; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Propafenone; Propiophenones; Tachycardia | 1985 |
Propafenone versus disopyramide: a double-blind randomized crossover trial in patients presenting chronic ventricular arrhythmias.
Topics: Adult; Aged; Cardiac Complexes, Premature; Chronic Disease; Disopyramide; Double-Blind Method; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Propafenone; Random Allocation | 1987 |
[Multicenter comparative studies of the effectiveness and tolerance of propafenone and disopyramide in the treatment of premature ventricular beats].
Topics: Adult; Aged; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; Drug Tolerance; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Poland; Propafenone | 1987 |
Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study.
Topics: Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic; Disopyramide; Electrocardiography; Female; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Random Allocation | 1988 |
Comparison of propafenone and disopyramide in the treatment of ventricular premature complexes: a randomized double blind crossover placebo controlled trial.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Gastrointestinal Diseases; Humans; Propafenone; Random Allocation | 1987 |
Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Propafenone; Propiophenones; Random Allocation; Tachycardia | 1985 |
[Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Echocardiography; Female; Heart Rate; Hemodynamics; Humans; Male; Mexiletine; Myocardial Contraction; Propafenone; Propiophenones; Propylamines | 1983 |
[The effect of anti-arrhythmic drugs on myocardial function (author's transl)].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Disease; Depression, Chemical; Disopyramide; Echocardiography; Humans; Lidocaine; Mexiletine; Middle Aged; Myocardial Contraction; Placebos; Propafenone; Propiophenones; Tocainide | 1982 |
Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Disopyramide; Drug Evaluation; Electrocardiography; Female; Humans; Male; Middle Aged; Propafenone; Propiophenones; Pyridines | 1982 |
Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Disopyramide; Double-Blind Method; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone | 1996 |
43 other study(ies) available for disopyramide and propafenone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Antiarrhythmic, electrophysiological and haemodynamic effects of prolonged oral dosing with Org 7797 in the anaesthetized rat.
Topics: Action Potentials; Administration, Oral; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Electrophysiology; Estrenes; Heart; Hemodynamics; Male; Mexiletine; Pentobarbital; Propafenone; Rats; Rats, Wistar | 1992 |
Effects of pentisomide and E-4031 on canine atrial flutter due to reentry: a comparative study with disopyramide and propafenone.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Disopyramide; Dogs; Electrocardiography; Electrophysiology; Heart Conduction System; Piperidines; Propafenone; Propylamines; Pyridines; Refractory Period, Electrophysiological | 1991 |
Effects of transcatheter cardioversion on chronic lone atrial fibrillation.
Topics: Atrial Fibrillation; Cardiac Catheterization; Cardiac Pacing, Artificial; Chronic Disease; Disopyramide; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Recurrence; Time Factors | 1991 |
Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts.
Topics: Anesthetics; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Dogs; Electrocardiography; Estrenes; Female; Male; Mexiletine; Myocardial Infarction; Propafenone; Ventricular Function | 1991 |
Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artificial; Disopyramide; Dogs; Electrocardiography; Flecainide; Heart Conduction System; Piperidines; Propafenone; Pyridines; Refractory Period, Electrophysiological | 1991 |
[Polycardiographic evaluation of the dynamics of left ventricular contraction in patients treated with disopyramide and propafenone].
Topics: Adult; Cardiac Complexes, Premature; Disopyramide; Electrocardiography; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Propafenone | 1986 |
Electrophysiologic effects of Org 7797, a new steroidal antiarrhythmic agent: comparison with class 1a, 1b, and 1c drugs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disopyramide; Electric Stimulation; Estrenes; Female; In Vitro Techniques; Lidocaine; Male; Membrane Potentials; Propafenone; Purkinje Fibers; Sodium Channels; Swine | 1989 |
Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Disopyramide; Dogs; Electrocardiography; Flecainide; Heart Conduction System; Heart Rate; Lidocaine; Piperidines; Propafenone; Sotalol | 1989 |
[Changes in thrombocyte-vascular hemostasis and cyclic nucleotide levels after anti-arrhythmia therapy in patients with ischemic heart disease].
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Female; Humans; Male; Mexiletine; Middle Aged; Nucleotides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Propafenone | 1989 |
[Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents].
Topics: Administration, Oral; Aged; Disopyramide; Drug Evaluation; Drug Resistance; Female; Humans; Male; Middle Aged; Propafenone; Quinidine; Tachycardia, Paroxysmal; Tachycardia, Supraventricular | 1989 |
Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Disopyramide; Drug Administration Schedule; Electrocardiography; Electrophysiology; Female; Flecainide; Humans; Male; Mexiletine; Middle Aged; Propafenone; Propylamines; Pyridines | 1987 |
Antiarrhythmic effects of a novel diamine derivative, AN-132, on several animal models of cardiac arrhythmias.
Topics: Aconitine; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chloroform; Disopyramide; Dogs; Epinephrine; Ethylenediamines; Female; Guinea Pigs; Halothane; Male; Mexiletine; Ouabain; Propafenone; Rats; Rats, Inbred Strains | 1987 |
The usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chromatography, High Pressure Liquid; Disopyramide; Electric Stimulation; Electrocardiography; Female; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Infarction; Propafenone; Propiophenones; Quinidine; Tachycardia, Paroxysmal; Time Factors; Tocainide; Verapamil | 1985 |
Aggravation of ventricular arrhythmia. A drug-induced complication.
Topics: Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrocardiography; Encainide; Flecainide; Humans; Mexiletine; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine | 1985 |
[Anti-arrhythmia agents (I): Quinidine, procainamide, disopyramide, encainide, propafenone and flecainide].
Topics: Anilides; Anti-Arrhythmia Agents; Disopyramide; Encainide; Flecainide; Humans; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine | 1985 |
[Effects of anti-arrhythmia agents on heart rate. Significance and importance].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Lidocaine; Propafenone; Propiophenones; Quinidine; Verapamil | 1981 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
[Effectiveness of propafenon and disopyramide in ventricular extrasystole. Comparative study].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Disopyramide; Female; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Propiophenones; Pyridines | 1982 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Complexes, Premature; Coronary Disease; Disopyramide; Electrocardiography; Humans; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Tachycardia; Tocainide | 1983 |
[Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Nadolol; Propafenone; Propanolamines; Propiophenones | 1984 |
Worsening of arrhythmias during pharmacological treatment.
Topics: Adolescent; Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Child; Disopyramide; Female; Follow-Up Studies; Humans; Lidocaine; Male; Middle Aged; Nadolol; Piperidines; Propafenone; Propanolamines; Propiophenones; Tocainide | 1984 |
[Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
Topics: Anti-Arrhythmia Agents; Disopyramide; Drug Evaluation; Heart Ventricles; Humans; Propafenone; Propiophenones; Recurrence; Tachycardia | 1984 |
[Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
Topics: Adult; Aged; Amiodarone; Death, Sudden; Disopyramide; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Arrest; Humans; Male; Metoprolol; Middle Aged; Pindolol; Propafenone; Propiophenones; Tachycardia; Ventricular Fibrillation | 1984 |
[The value of antitachycardia pacemaker therapy in patients with Wolff-Parkinson-White syndrome].
Topics: Anti-Arrhythmia Agents; Bundle of His; Digitalis Glycosides; Disopyramide; Electrocardiography; Humans; Mexiletine; Pacemaker, Artificial; Propafenone; Propiophenones; Tachycardia; Verapamil; Wolff-Parkinson-White Syndrome | 1983 |
[The effect of disopyramide, mexiletine and propafenon after intravenous and oral administration on left ventricular function in the M-mode echocardiogram].
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Drug Therapy, Combination; Echocardiography; Female; Heart; Heart Ventricles; Humans; Injections, Intravenous; Male; Mexiletine; Propafenone; Propiophenones | 1982 |
Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect.
Topics: Amiodarone; Anti-Arrhythmia Agents; Binding, Competitive; Disopyramide; Dose-Response Relationship, Drug; Humans; Lidocaine; Metoprolol; Propafenone; Receptors, Thyroid Hormone; Sotalol; Triiodothyronine; Verapamil | 1995 |
Efficacy of type 1C antiarrhythmic agents for treatment of resistant atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Encainide; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Procainamide; Propafenone; Quinidine; Recurrence; Retrospective Studies | 1993 |
Propafenone and disopyramide enhance post-ischemic contractile and metabolic recovery of perfused hearts.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cations; Creatine Kinase; Disopyramide; Heart; Male; Myocardial Contraction; Myocardium; Propafenone; Purine Nucleosides; Rats; Rats, Wistar; Reperfusion Injury; Ventricular Function, Left | 1993 |
[Effects of propafenone on the parameters of body surface electrocardiogram in comparison with those of disopyramide].
Topics: Aged; Disopyramide; Electrocardiography; Female; Humans; Male; Middle Aged; Propafenone | 1993 |
Antiarrhythmic agents act differently on the activation phase of the ACh-response in guinea-pig atrial myocytes.
Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Disopyramide; Electric Conductivity; Flecainide; Guinea Pigs; Lidocaine; Male; Myocardium; Potassium; Potassium Channels; Propafenone | 1993 |
[Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Disopyramide; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Imidazoles; Male; Middle Aged; Predictive Value of Tests; Propafenone; Quinidine; Risk Factors | 1997 |
Atrial fibrillation: rate control often better than rhythm control.
Topics: Adult; Aged; Amiodarone; Anticoagulants; Arrhythmia, Sinus; Atrial Fibrillation; Canada; Disopyramide; Electric Countershock; Flecainide; Heart Rate; Humans; Netherlands; Platelet Aggregation Inhibitors; Propafenone; Quinidine; Sotalol; United States | 2004 |
Pilsicainide in breast milk from a mother: comparison with disopyramide and propafenone.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Breast Feeding; Disopyramide; Female; Humans; Lidocaine; Milk, Human; Propafenone | 2005 |
In Silico Assessment of Class I Antiarrhythmic Drug Effects on
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Computer Simulation; Disopyramide; Heart Atria; Homeobox Protein PITX2; Homeodomain Proteins; Humans; Mice; Propafenone; Quinidine; Transcription Factors | 2021 |